Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/29/2026

1. V
2. KLAC
3. PYPL
4. BE
5. SWKS
6. F
7. STX
8. CSGP
9. SPY
10. VRNS

Go back to Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 46.71 -1.02 (2.14%)
Previous Close $47.73    52 Week High $26.84 
Open $47.60    52 Week Low $9.51 
Day High $48.00    P/E N/A 
Day Low $46.35    EPS $-2.62 
Volume 244,094